This archive report was first published on 2 July 2020.
On June 25, China's Central Military Commission approved the use of the Ad5-nCoV vaccine by the military for a period of one year, according to CanSino Biologics.
The vaccine candidate was developed jointly by CanSino and the Academy of Military Science's research institute, and has shown potential in preventing diseases caused by the coronavirus, which has killed half a million people globally.
CanSino declined to disclose whether the inoculation of the vaccine candidate is mandatory or optional, citing commercial secrets.
The military approval follows China's decision to offer two other vaccine candidates to employees at state-owned firms traveling overseas.
Over a dozen vaccines from more than 100 candidates globally are being tested in humans, but no vaccine has yet been approved for commercial use against the illness caused by the new coronavirus.
Published on July 2, 2020.
